Published in
Dove Press, Drug Design, Development and Therapy, (Volume 13), p. 3705-3715, 2019
DOI: 10.2147/dddt.s207856
Links
Tools
<p>Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis</p>
Journal article published in 2019 by
Uma Ramaswami 
,
Michael Beck,
Derralynn Hughes,
Christoph Kampmann,
Jaco Botha,
Guillem Pintos-Morell ,
Michael L. West ,
Dau-Ming Niu,
Kathy Nicholls ,
Roberto Giugliani
,
Michael Beck,
Derralynn Hughes,
Christoph Kampmann,
Jaco Botha,
Guillem Pintos-Morell ,
Michael L. West ,
Dau-Ming Niu,
Kathy Nicholls ,
Roberto Giugliani
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 